Variant report
Variant | nsv599406 |
---|---|
Chromosome Location | chr5:112965930-112982650 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:112961563..112964546-chr5:112979790..112981581,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545700608 | chr5:112970808-112970809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150483862 | chr5:112970828-112970829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576904194 | chr5:112970829-112970830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181529155 | chr5:112970857-112970858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560341280 | chr5:112970893-112970894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs527948658 | chr5:112970897-112970898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10064031 | chr5:112970924-112970925 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs186141124 | chr5:112970955-112970956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528398023 | chr5:112970974-112970975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190859587 | chr5:112970975-112970976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10050530 | chr5:112971042-112971043 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs181916517 | chr5:112971090-112971091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547595279 | chr5:112971098-112971099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141060414 | chr5:112971108-112971109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs565904280 | chr5:112971118-112971119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs377533301 | chr5:112971121-112971122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs35552641 | chr5:112971132-112971133 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs2972677 | chr5:112971137-112971138 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs569624560 | chr5:112971140-112971141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369755718 | chr5:112971141-112971142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs375653634 | chr5:112971150-112971151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558302156 | chr5:112971170-112971171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs17135829 | chr5:112971192-112971193 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs138312468 | chr5:112971206-112971207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568849543 | chr5:112971255-112971256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs370724545 | chr5:112971300-112971301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs553910348 | chr5:112971350-112971351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537520840 | chr5:112971390-112971391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs149461642 | chr5:112971392-112971393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542864422 | chr5:112971404-112971405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561241918 | chr5:112971407-112971408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186566283 | chr5:112971471-112971472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185912039 | chr5:112971477-112971478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377672781 | chr5:112971479-112971480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571032699 | chr5:112971480-112971481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145750947 | chr5:112971488-112971489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535385166 | chr5:112971498-112971499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs13154055 | chr5:112971516-112971517 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs532612815 | chr5:112971573-112971574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547927884 | chr5:112971581-112971582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs138751485 | chr5:112971590-112971591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs529918849 | chr5:112971605-112971606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189788658 | chr5:112971609-112971610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142749211 | chr5:112971646-112971647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536973481 | chr5:112971651-112971652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs960691 | chr5:112971654-112971655 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs182965731 | chr5:112971666-112971667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs960692 | chr5:112971676-112971677 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs150949750 | chr5:112971688-112971689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs147415011 | chr5:112971696-112971697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Autism | 22495309 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:112970800-112971200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr5:112970800-112971200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr5:112971200-112974200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr5:112974200-112974600 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
5 | chr5:112974600-112976400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
6 | chr5:112977600-112977800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |